Clinical trial
Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
NCT00324454 · Duke University, Other · Completed
Key facts
| NCT number | NCT00324454 |
|---|---|
| Title | Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease |
| Official title | A Pilot Trial of Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease |
| Lead sponsor | Duke University, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Motor Neuron Disease, Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, Progressive Muscular Atrophy |
| Intervention type | Biological |
| Interventions | Levetiracetam |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | May 11, 2006 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: